Sort by
Keyphrases
COVID-19
100%
Pediatric
57%
Meta-analysis
55%
Direct Oral Anticoagulants
55%
Emicizumab
49%
Hospitalization
48%
Hospitalized Patients
48%
Tertiary Care Hospital
43%
Hemophilia
42%
Obesity
36%
Artificial Intelligence
36%
Hydroxychloroquine
36%
Systematic Meta-analysis
36%
Pediatric Patients
34%
Troponin Levels
33%
Confidence Interval
32%
Etiology
30%
Venous Thromboembolism
28%
Elevated Troponin
27%
Retrospective Cohort Study
26%
Risk Factors
26%
Anticoagulation
25%
Myocardial Injury
24%
Clinical Characteristics
24%
Emergency Department Visits
24%
Clinical Outcomes
23%
Recurrent Venous Thromboembolism
23%
Adult Patients
21%
Machine Learning Models
21%
Haemophilia Treatment Centre
21%
Pregnancy Outcome
21%
Immune Thrombocytopenia
20%
Antibody Titer
20%
Pediatric Immune Thrombocytopenia
20%
Systemic Lupus Erythematosus
19%
Clinical Presentation
19%
Anticoagulant Treatment
18%
Splenic Infarction
18%
Serum Creatinine Level
18%
Splanchnic Vein Thrombosis
18%
Neutrophil-to-lymphocyte Ratio
18%
International Normalized Ratio
18%
Folate Levels
18%
Response to Treatment
18%
Infection Risk Factors
18%
Prognostic Role
18%
End-stage Kidney Disease
18%
Risk Outcomes
18%
Pneumonia
18%
Clinical Conditions
18%
Medicine and Dentistry
Systematic Review
77%
Pediatrics
75%
Meta-Analysis
39%
Idiopathic Thrombocytopenic Purpura
36%
Haemophilia A
36%
Hydroxychloroquine
36%
Pediatrics Patient
33%
Emicizumab
30%
Venous Thromboembolism
28%
Retrospective Study
28%
Anticoagulation
25%
Retrospective Cohort Study
24%
Anemia
24%
Diagnostic Accuracy
22%
Emergency Department
22%
Anticoagulant Therapy
19%
Systemic Lupus Erythematosus
19%
End Stage Renal Disease
18%
Creatinine
18%
Splenic Infarction
18%
Glomerular Filtration Rate
18%
Phlebothrombosis
18%
Acute Pulmonary Embolism
18%
COVID-19
18%
Delivery Complication
18%
Obstetrics
18%
Hematology
18%
Immunoglobulin
18%
Lymphocyte
18%
Neutrophil
18%
Bleeding
18%
Thrombocytosis
18%
Iron Deficiency
18%
Ferritin
18%
Antiphospholipid Syndrome
18%
Nephrology
18%
Atrial Fibrillation
18%
Direct Oral Anticoagulant
18%
Hyperbaric Medicine
18%
Air Embolism
18%
Lung Biopsy
18%
Neurologic Disease
18%
Cerebral Venous Sinus Thrombosis
18%
Platelet
16%
Blood Clotting Factor 8
15%
Invasive Procedure
15%
Chronic Kidney Disease
14%
Autoimmune Disease
14%
Blastocyst
13%
Side Effect
12%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
55%
Haemophilia A
50%
Emicizumab
46%
Coronavirinae
36%
Idiopathic Thrombocytopenic Purpura
36%
Diseases
36%
Hydroxychloroquine
36%
Pandemic
32%
Retrospective Study
29%
Bleeding
28%
Venous Thromboembolism
28%
Anticoagulant Agent
27%
Creatinine
21%
Systemic Lupus Erythematosus
19%
Troponin
18%
Thrombin
18%
COVID-19 Vaccine
18%
End Stage Renal Disease
18%
Morbid Obesity
18%
Folic Acid
18%
Spleen Infarction
18%
Vein Thrombosis
18%
Case-Control Study
18%
Delivery Complication
18%
Immunoglobulin
18%
Thrombophilia
18%
Remission
18%
Thrombocytosis
18%
Antiphospholipid Syndrome
18%
Atrial Fibrillation
18%
Recurrent Disease
16%
Chronic Kidney Failure
15%
Cohort Study
13%
Population Study
12%
mRNA Vaccine
12%
Blood Clotting Factor 8
12%
Hospital Mortality
11%
Acute Kidney Failure
11%
Autoimmune Disease
11%
Recurrence Risk
10%
Adverse Event
10%
Mortality Rate
10%
Kidney Disease
9%
Side Effect
9%
Immunosuppressive Agent
9%
Blood Clotting Disorder
8%
Antivitamin K
8%
Hemostatic Agent
6%
Blood Clotting Factor 8 Inhibitor
6%
Sepsis
6%